Charting Successful Outcomes by Raising Brand Awareness and Generating Leads for an Oncology CRO.

TD2 is a world-class oncology contract research organization (CRO) that partners with innovative biotech and pharmaceutical companies with the purpose-driven goal to bring new cancer treatments to patients as quickly as possible. While one of the most effective in successfully advancing cancer treatments through clinical trials, TD2 had low brand awareness and needed to distinguish themselves from larger, established competitors.

A brand strategy workshop provided research and insights needed to solidify TD2’s brand position along with a comprehensive marketing strategy that would differentiate and highlight their key brand benefits of: responsiveness, experience, adaptability, and genuine passion for patient care. A leadership and brand awareness campaign was then born.

With the new brand platform in hand, polish was applied to TD2’s tone and visual language to express an authoritative presence within the industry. Once established this permeated through all of the brand’s touch points such as website, digital campaigns, white papers. An exhibit design and collateral for events such as the American Society of Clinical Oncologists annual meeting were a part of the strategic mix. Most notable was a partnership with Fierce BioTech to customize sponsored content opportunities and generate qualified leads.

In less than two years TD2 went from relatively unknown to earning a reputation as an experienced oncology CRO. To get there; 19 contributed articles in top-tier industry trades were placed, website traffic increased by 142%, six targeted email campaigns generated 800+ sales leads, and approximately 475 LinkedIn posts were produced to increase follows by 233%.